 |
인쇄하기
취소
|
LG Life Sciences teams up with Sanofi-Aventis Korea
LG Life Sciences said Monday that it has established a marketing and distribution partnership with Sanofi-Aventis Korea.
Under the deal, Sanofi-Aventis Korea will be in charge of selling LGIS’s diabetes treatment Gemiglo (gemigliptin) using its extensive domestic distribution network, with the Korea-based pharmaceutical company responsible for marketing efforts.
The Korea Food and Drug A...
Under the deal, Sanofi-Aventis Korea will be in charge of selling LGIS’s diabetes treatment Gemiglo (gemigliptin) using its extensive domestic distribution network, with the Korea-based pharmaceutical company responsible for marketing efforts.
The Korea Food and Drug A...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.